Martinez Bueno A, Molina MA, Fielding A, et al. Disruptive mutations in TP53 associate with survival benefit in a PARPi trial in ovarian cancer. ESMO 2017, abstract LBA42.
“Een arts op TikTok bereikt jongeren via hun leefwereld”
apr 2024 | Longoncologie